Most of the 12000 HIV-positive people who have developed resistance to first-line anti-retroviral treatment need second-line Aids drugs, namely Kaletra and ...
The three drugs were efavirenz, Kaletra and Plavix. The first two are for Aids and are manufactured by Merck's MSD (Thailand) and Abbott Laboratories ...
Abbott spokeswoman Laureen Cassidy said Abbott did not increase the price of Norvir to promote Kaletra and that the increase did not affect other drug ...
... known as Aluvia in developing countries and Kaletra in developed countries, have been made available to children living with HIV/AIDS in Uganda. ...
... that independently predicted nontarget drug blood levels: greater body weight, use of efavirenz (Sustiva) and use of lopinavir/ritonavir (Kaletra). ...
... the government in January announced a policy to override patents of three Aids and heart drugs sold under the trade names Efavirenz, Kaletra and Plavix. ...
... that independently predicted nontarget drug blood levels: greater body weight, use of efavirenz (Sustiva) and use of lopinavir/ritonavir (Kaletra). ...
Thailand has so far suspended patents for the blockbuster heart drug Plavix and the AIDS medicines Kaletra and Efavirenz, and has already begun importing ...
The company has also made its Kaletra drug available in developed countries. According to the company, the drug has been shipped to Uganda under a waiver ...
Thailand has so far imposed compulsory licenses for the blockbuster heart drug Plavix and the AIDS medicines Kaletra and Efavirenz. ...